<p>Chronic obstructive pulmonary disease (COPD) is a chronic lung disease characterized by airway obstruction and inflammation. Non-typeable <i>Haemophilus influenzae</i> (NTHi) lung infections are common in COPD, promoting frequent exacerbations and accelerated lung function decline. The relationship with immune responses and NTHi are poorly understood. Herein, we comprehensively characterized the respiratory microbiome and mycobiome of patients while investigating microbial dynamics and host immune changes attributable to NTHi killing activity. Mild-to-moderate COPD patients encompassing frequent and infrequent exacerbators and healthy volunteers (HV) were enrolled. Microbial composition, proteomics and NTHi killing activity was analyzed using bronchoalveolar lavage fluid (BALF). In addition, antigen–antibody titers in sera to COPD pathogens were determined using a multiplex assay. Differential abundance analysis revealed an enrichment of <i>Actinobacteria</i> and <i>Bacteroidetes</i> in the BALF of COPD and HV subjects respectively. Significant differences in the IgA titer response were observed against NTHi antigens in COPD vs. HV. Notably, there was also significantly greater killing activity against NTHi in BALF from COPD vs. HV subjects (OR = 5.64; 95% CI = 1.75–20.20; <i>p</i> = 0.001). Stratification of COPD patients by NTHi killing activity identified unique microbial and protein signatures wherein <i>Firmicutes</i>, <i>Actinobacteria</i> and haptoglobin were enriched in patients with killing activity. We report that differences in host immune responses and NTHi-killing activity are associated with microbiome changes in mild-to-moderate COPD. This is suggestive of a potential link between the respiratory&#xa0;microbiome and immune activity against NTHi in the context of COPD pathogenesis even at this disease stage.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

NTHi killing activity is reduced in COPD patients and is associated with a differential microbiome

  • Vancheswaran Gopalakrishnan,
  • Ben Sparklin,
  • Jung Hwan Kim,
  • Jerome Bouquet,
  • Margaret Kehl,
  • Tara Kenny,
  • Christopher Morehouse,
  • Carolina Caceres,
  • Paul Warrener,
  • Ventzislava A. Hristova,
  • Susan Wilson,
  • Harini Shandilya,
  • Arnita Barnes,
  • Alexey Ruzin,
  • Junmin Wang,
  • Lisa Oberg,
  • Bastian Angermann,
  • Christopher McCrae,
  • Adam Platt,
  • Daniel Muthas,
  • Sonja Hess,
  • Christine Tkaczyk,
  • Bret R. Sellman,
  • Kristoffer Ostridge,
  • Maria G. Belvisi,
  • Tom M. A. Wilkinson,
  • Karl J. Staples,
  • Antonio DiGiandomenico,
  • Vancheswaran Gopalakrishnan,
  • Christopher Morehouse,
  • Jerome Bouquet,
  • Bret Sellman,
  • Paul Warrener,
  • Carolina Caceres,
  • Ventzislava A. Hristova,
  • Sonja Hess,
  • Raghothama Chaerkady,
  • Matthew S. Glover,
  • Steven Novick,
  • Junmin Wang,
  • Bairu Zhang,
  • Tianhui Zhang,
  • Natalie van Zuydam,
  • Christopher McCrae,
  • Daniel Muthas,
  • Michael Hühn,
  • Lisa Öberg,
  • Hanna Duan,
  • Glenda Lassi,
  • Gary Sims,
  • Kristoffer Ostridge,
  • Alex Mackay,
  • Adam Platt,
  • Antonio DiGiandomenico,
  • Jodie Ackland,
  • Ashley I. Heinson,
  • D. Cellura,
  • Anthony D. Postle,
  • C. Mirella Spalluto,
  • Kerry Day,
  • Alex Hicks,
  • Nicholas P. Williams,
  • Karl J. Staples,
  • Tom M. A. Wilkinson,
  • Hannah Burke,
  • Anna Freeman,
  • Maria G. Belvisi,
  • Sarah Bawden,
  • Esther Nyimbili,
  • Laura Presland,
  • Nicola Rayner,
  • Pedro Rodrigues,
  • Andria Staniford,
  • Alastair Watson,
  • Graham Belfield,
  • Stephanie Ashenden,
  • Damla Etal,
  • Aurelie Bornot,
  • Fredrik Karlsson,
  • Karl Nordström,
  • Outi Vaarala,
  • Chia-Chien Chiang,
  • Shameer Khader,
  • Wen Yu,
  • Xiaotao Qu,
  • Bruce Thompson,
  • Ulrika Edvardsson,
  • Stephen Harden

摘要

Chronic obstructive pulmonary disease (COPD) is a chronic lung disease characterized by airway obstruction and inflammation. Non-typeable Haemophilus influenzae (NTHi) lung infections are common in COPD, promoting frequent exacerbations and accelerated lung function decline. The relationship with immune responses and NTHi are poorly understood. Herein, we comprehensively characterized the respiratory microbiome and mycobiome of patients while investigating microbial dynamics and host immune changes attributable to NTHi killing activity. Mild-to-moderate COPD patients encompassing frequent and infrequent exacerbators and healthy volunteers (HV) were enrolled. Microbial composition, proteomics and NTHi killing activity was analyzed using bronchoalveolar lavage fluid (BALF). In addition, antigen–antibody titers in sera to COPD pathogens were determined using a multiplex assay. Differential abundance analysis revealed an enrichment of Actinobacteria and Bacteroidetes in the BALF of COPD and HV subjects respectively. Significant differences in the IgA titer response were observed against NTHi antigens in COPD vs. HV. Notably, there was also significantly greater killing activity against NTHi in BALF from COPD vs. HV subjects (OR = 5.64; 95% CI = 1.75–20.20; p = 0.001). Stratification of COPD patients by NTHi killing activity identified unique microbial and protein signatures wherein Firmicutes, Actinobacteria and haptoglobin were enriched in patients with killing activity. We report that differences in host immune responses and NTHi-killing activity are associated with microbiome changes in mild-to-moderate COPD. This is suggestive of a potential link between the respiratory microbiome and immune activity against NTHi in the context of COPD pathogenesis even at this disease stage.